Great Point Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
+50,000
New +$1.55M 0.41% 40
2024
Q1
Sell
-875,044
Closed -$24.3M 36
2023
Q4
$24.3M Hold
875,044
4.14% 8
2023
Q3
$24.5M Buy
875,044
+463,591
+113% +$13.6M 4.46% 6
2023
Q2
$12.9M Buy
+411,453
New +$12.5M 2.52% 17
2023
Q1
Sell
-46,185
Closed -$1.21M 45
2022
Q4
$1.21M Sell
46,185
-461,315
-91% -$11M 0.24% 40
2022
Q3
$11.3M Buy
507,500
+145,864
+40% +$3.79M 2.73% 14
2022
Q2
$10.8M Buy
+361,636
New +$10.4M 2.58% 18

Other funds holding ALKS

Great Point Partners's ALKS Position: Q1 2026 in Review

Great Point Partners opened a new position in Alkermes (ALKS) in Q1 2026: 50,000 shares worth $1.77M. The stake represents 0.41% of the portfolio and ranks #40 among its holdings. This is a return to the name: Great Point Partners previously reported a position in ALKS as recently as Q4 2023.

Great Point Partners first reported a position in ALKS in Q2 2022 and has held it in 7 quarters since. The position peaked at $24.5M in Q3 2023. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Great Point Partners held 50,000 shares of Alkermes worth $1.77M as of Q1 2026.
  • Alkermes was a new Great Point Partners position in Q1 2026.
  • Alkermes made up 0.41% of Great Point Partners's portfolio in Q1 2026, its #40 holding.
  • Great Point Partners first reported a position in Alkermes in Q2 2022 and has held it in 7 quarters since.
  • Great Point Partners's Alkermes position peaked at $24.5M in Q3 2023.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Great Point Partners's 13F filing for Q1 2026, filed 15 May 2026.